This episode of Oncology Data Advisor features Dr. Shreyaskumar Patel, University of Texas MD Anderson Cancer Center, in a discussion that covers the changing treatment landscape, adverse events of concern with novel therapies, and advice for members of the cancer care team as they seek to optimize outcomes for patients with GIST.

The second episode of Oncology Data Advisor with Dr. Benson considers recent developments in genomic testings and targeted therapies, supportive care measures that can optimize quality of life, and strategies that can be utilized to improve outcomes of patients with pancreatic cancer.

Our third Oncology Data Advisor™ episode talks to Gilles Salles, MD, PhD, about efficacy of newly developed therapies, adverse events associated with these treatments, ongoing research, and advice for clinicians seeking to optimize outcomes for patients with MCL.

In the fourth episode of Oncology Data Advisor, Mitesh J. Borad, MD, shares insights on managing cholangiocarcinoma in a discussion that covers the changing treatment landscape, adverse events of concern with novel therapies, and advice for members of the cancer care team as they seek to optimize outcomes for patients with this disease.

This bonus episode of Oncology Data Advisor features a discussion between Mark G. Kris, MD, Memorial Sloan Kettering Cancer Center, and Nathan Pennell, MD, PhD, Cleveland Clinic Taussig Cancer Center, on novel treatment sequences for non-small cell lung cancer.